Skip to main content
OpenTrials

Clinical trial condition

Recurrent Colon Adenocarcinoma

Explore clinical trials studying Recurrent Colon Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Colon Adenocarcinoma trial results

Completed

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

NCT04109924

Conditions
Advanced Colorectal Carcinoma, Colonic Diseases, Colonic Neoplasms, +37 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions